FDA drafts guidance on drug interaction labeling
Regulatory NewsJeff Craven
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesGuidancePharmaceuticalsUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJeff CravenAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesGuidancePharmaceuticalsUnited StatesUS Food and Drug Administration (FDA)